| Dr Terese Marie Tomanek, DC | |
|
2900 Piedmont Ave, Duluth, MN 55811-2915 | |
| (218) 727-8228 | |
| (218) 727-7771 |
| Full Name | Dr Terese Marie Tomanek |
|---|---|
| Gender | Female |
| Speciality | Chiropractor |
| Location | 2900 Piedmont Ave, Duluth, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104848969 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 1771 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terese Marie Tomanek, DC 2900 Piedmont Ave, Duluth, MN 55811-2915 Ph: (218) 727-8228 | Dr Terese Marie Tomanek, DC 2900 Piedmont Ave, Duluth, MN 55811-2915 Ph: (218) 727-8228 |
News Archive
"Finding a safe, effective AIDS vaccine has, thus far, proved elusive even after some $8 billion invested from 2001-2011 into vaccine research and development," PlusNews reports in an article examining ongoing HIV vaccine research efforts. "Scientists point to HIV's Houdini-like ability to escape immune system attack, and less-than-strategic use of funds over the past decade, as reasons for the continued hunt," the news service writes.
Genetic analysis of samples collected as the Zika virus (ZIKV) spread throughout the Americas after its introduction in 2013 or 2014 has shown that the virus circulated undetected for up to a year in some regions before it came to the attention of public health authorities.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
Immune Pharmaceuticals Inc. announced today that it has initiated its Phase II Ulcerative Colitis clinical trial and is scheduled to initiate its Phase II Bullous Pemphigoid clinical trial on July 1, 2015. Study Initiation is the training of hospital staff to allow for patient screening and immediate patient enrollment into the clinical trial upon selection.
› Verified 6 days ago
Mary Clare Cooley, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 5722 Homestead Rd, Duluth, MN 55804 Phone: 218-525-3630 Fax: 218-525-3630 | |
Dr. Troy Christopher Bolen, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2730 Piedmont Ave, Duluth, MN 55811 Phone: 218-728-3630 Fax: 218-786-0399 | |
Miller Hill Chiropractic, Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 1705 Miller Trunk Hwy, Duluth, MN 55811 Phone: 218-740-2777 Fax: 218-740-2778 | |
Dr. Stephanie Michelle West, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 404 W Superior St, Suite 225c, Duluth, MN 55802 Phone: 218-722-2004 | |
Dr. Claudia Carlson Cottrell, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 31 W Superior St, Ste. 501, Duluth, MN 55802 Phone: 218-740-3379 Fax: 218-740-3380 | |
Robert J Torgrimson Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 1320 Kenwood Ave, Duluth, MN 55811 Phone: 218-728-3686 Fax: 218-728-2996 | |
Dr. Tanner Kutzler, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2524 Maple Grove Rd, Duluth, MN 55811 Phone: 218-722-1423 Fax: 218-722-1423 |